IPO Boutique Research, Color & More Information for Subscribers
Company: Eidos Therapeutics, Inc. Symbol: EIDX Description: They are a clinical stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin, or TTR, amyloidosis, or ATTR. Trade Date: 6/20 Shares: 6.25 million Price Range: $15.00-$17.00 Underwriter(s): J.P. Morgan, BofA Merrill Lynch Co-Manager(s): Barclays Terms Added: 6-8-18 Link to[…]
Company: Aptinyx, Inc. Symbol: APTX Description: They are a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel, proprietary, synthetic small molecules for the treatment of brain and nervous system disorders. Trade Date: 6/21 Shares: 5.33 million Price Range: $14.00-$16.00 Underwriter(s): J.P. Morgan, Cowen, Leerink Partners, BMO Capital Markets Terms Added: 6-11-18[…]
Company: AVROBIO, Inc. Symbol: AVRO Description: They are a clinical stage gene therapy company focused on developing potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose. Trade Date: 6/21 Shares: 4.4 million Price Range: $16.00-$18.00 Underwriter(s): Morgan Stanley, Cowen, Wells Fargo Securities Co-Manager(s): Wedbush Pacgrow Terms Added: 6-11-18 Link[…]
Company: i3 Verticals, Inc. Symbol: IIIV Description: They deliver seamless integrated payment and software solutions to small- and medium-sized businesses and organizations in strategic vertical markets. Trade Date: 6/21 Shares: 6.65 million Price Range: $11.00-$13.00 Underwriter(s): Cowen, Raymond James, KeyBanc Capital Markets Terms Added: 6-11-18 Link to Prospectus Link to Retail Roadshow Business: They have built[…]
Company: Magenta Therapeutics, Inc. Symbol: MGTA Description: They are a clinical-stage biotechnology company developing novel medicines to bring the curative power of bone marrow transplant to more patients. Trade Date: 6/21 Shares: 6.67 million Price Range: $14.00-$16.00 Underwriter(s): J.P. Morgan, Goldman Sachs, Cowen Co-Manager(s): Wedbush PacGrow Terms Added: 6-8-18 Link to Prospectus Link to Retail[…]
Company: Xeris Pharmaceuticals, Inc. Symbol: XERS Description: They are a specialty pharmaceutical company leveraging our novel non-aqueous formulation technology platforms, XeriSol and XeriJect, to develop and commercialize ready-to-use injectable and infusible drug formulations. Trade Date: 6/21 Shares: 5 million Price Range: $14.00-$16.00 Underwriter(s): Jefferies, Leerink Partners, RBC Capital, Mizuho Securities Terms Added: 6-11-18 Link to[…]
Company: Electrocore, LLC Symbol: ECOR Description: They are a commercial-stage bioelectronic medicine company with a platform non-invasive vagus nerve stimulation therapy initially focused on neurology and rheumatology. Trade Date: 6/22 Shares: 4.33 million Price Range: $14.00-$16.00 Underwriter(s): Evercore ISI, JMP Securities, BTIG Terms Added: 6-5-18 Link to Prospectus Link to Retail Roadshow Business: They are a[…]
Place more than four decades of experience on your team. We use a combination of underwriter contacts, global sources and contacts at large institutional funds to provide the TRUEST picture of how an IPO is shaping up prior to its debut. We are on your team. Additionally, we provide comprehensive research to outline short and[…]
Company: Puxin Limited Symbol: NEW Description: They are a successful consolidator of the after-school education industry in China. Trade Date: 6/15 Shares: 7.2 million Price Range: $17.00-$20.00 Underwriter(s): Citigroup, Deutsche Bank, Barclays, Haitong International, CICC Terms Added: 6-1-18 Link to Prospectus Link to Retail Roadshow Business: They are a successful consolidator of the after-school education industry[…]
Company: Avalara, Inc. Symbol: AVLR Description: They provide a leading suite of cloud-based solutions designed to improve accuracy and efficiency by automating the processes of determining taxability, identifying applicable tax rates, determining and collecting taxes, preparing and filing returns, remitting taxes, maintaining tax records, and managing compliance documents. Trade Date: 6/15 Shares: 7.5 million Price[…]
Company: U.S. Xpress Enterprises, Inc. Symbol: USX Description: They are the fifth largest asset-based truckload carrier in the United States by revenue, generating over $1.5 billion in total operating revenue in 2017. Trade Date: 6/14 Shares: 18.05 million Price Range: $18.00-$20.00 Underwriter(s): BofA Merrill Lynch, Morgan Stanley, J.P. Morgan, Wells Fargo Securities Co-Manager(s): Stephens Inc.,[…]
Company: Charah Solutions, Inc. Symbol: CHRA Description: They are a leading provider of mission-critical environmental and maintenance services to the power generation industry. Trade Date: 6/14 Shares: 7.4 million Price Range: $16.00-$18.00 Underwriter(s): Morgan Stanley, BofA Merrill Lynch, Stifel Co-Manager(s): Macquarie Capital, First Analysis Securities, Houlihan Lokey Terms Added: 6-4-18 Link to Prospectus Link to[…]
Company: Adaptive Insights, Inc. Symbol: ADIN Description: They are a leading provider of cloud-based software to modernize business planning. Trade Date: 6/14 Shares: 8.2 million Price Range: $13.00-$15.00 Underwriter(s): Morgan Stanley, BofA Merrill Lynch, Jefferies, RBC Capital Co-Manager(s): JMP Securities, Oppenheimer & Co. Terms Added: 6-4-18 Link to Prospectus Link to Retail Roadshow Business: They are[…]
IPO Boutique keeps apprised of the active pipeline. Currently there are 57 active IPOs in the pipeline as of May 18, 2018. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why “looks may be perceiving” when it comes to the IPO pipeline in this article. NEW FILINGS Company: M17[…]
Place more than four decades of experience on your team. We use a combination of underwriter contacts, global sources and contacts at large institutional funds to provide the TRUEST picture of how an IPO is shaping up prior to its debut. We are on your team. Additionally, we provide comprehensive research to outline short and[…]
Company: Scholar Rock Holding Corporation Symbol: SRRK Description: They are a biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Trade Date: 5/24 Shares: 5.36 million Price Range: $13.00-$15.00 Underwriter(s): Jefferies, Cowen, BMO Capital Co-Manager(s): Wedbush[…]
Company: Kiniksa Pharmaceuticals, Ltd. Symbol: KNSA Description: They are a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Trade Date: 5/24 Shares: 7 million Price Range: $17.00-$19.00 Underwriter(s): Goldman Sachs, J.P. Morgan Co-Manager(s): JMP Securities, Wedbush PacGrow Terms Added: 5-14-18[…]
Company: Iterum Therapeutics plc Symbol: ITRM Description: They are a pharmaceutical company dedicated to developing and commercializing sulopenem to be potentially the first and only oral and intravenous (IV) branded penem available globally. Trade Date: 5/25 Shares: 5.33 million Price Range: $14.00-$16.00 Underwriter(s): Leerink Partners, RBC Capital Partners Co-Manager(s): Guggenheim Securities, Needham & Co. Terms[…]
Company: GreenSky, Inc. Symbol: GSKY Description: They are a leading technology company that powers commerce at the point of sale. Trade Date: 5/24 Shares: 34.1 million Price Range: $21.00-$23.00 Underwriter(s): Goldman Sachs & Co., J.P. Morgan, Morgan Stanley, BofA Merrill Lynch, Citigroup, Credit Suisse, SunTrust Robinson Humphrey Co-Manager(s): Raymond James, Sandler O’ Neill, Fifth Third[…]
Company: EVO Payments, Inc. Symbol: EVOP Description: They are a global merchant acquirer and payment processor servicing approximately 525,000 merchants in North America and Europe and processing more than 900 million transactions in North America and 1.7 billion transactions in Europe annually. Trade Date: 5/23 Shares: 14 million Price Range: $14.00-$16.00 Underwriter(s): J.P. Morgan, BofA[…]